BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 16964594)

  • 1. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.
    Morioka D; Egawa H; Kasahara M; Jo T; Sakamoto S; Ogura Y; Haga H; Takada Y; Shimada H; Tanaka K
    Liver Transpl; 2007 Jan; 13(1):80-90. PubMed ID: 16964594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of living donor liver transplantation for primary biliary cirrhosis.
    Kaneko J; Sugawara Y; Tamura S; Aoki T; Hasegawa K; Yamashiki N; Kokudo N
    Transpl Int; 2012 Jan; 25(1):7-12. PubMed ID: 21923804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report.
    Opelz G; Döhler B
    Transplantation; 2010 Aug; 90(3):292-7. PubMed ID: 20548266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Balan V; Ruppert K; Demetris AJ; Ledneva T; Duquesnoy RJ; Detre KM; Wei YL; Rakela J; Schafer DF; Roberts JP; Everhart JE; Wiesner RH
    Hepatology; 2008 Sep; 48(3):878-88. PubMed ID: 18752327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
    Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
    Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes of Living-Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study.
    Egawa H; Sakisaka S; Teramukai S; Sakabayashi S; Yamamoto M; Umeshita K; Uemoto S
    Am J Transplant; 2016 Apr; 16(4):1248-57. PubMed ID: 26731039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity.
    Manousou P; Arvaniti V; Tsochatzis E; Isgro G; Jones K; Shirling G; Dhillon AP; O'Beirne J; Patch D; Burroughs AK
    Liver Transpl; 2010 Jan; 16(1):64-73. PubMed ID: 19866449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center.
    Hasegawa K; Sugawara Y; Imamura H; Ikeda M; Kokudo N; Makuuchi M
    Transpl Int; 2005 Jul; 18(7):794-9. PubMed ID: 15948857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
    Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
    Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Jarcho J; Naftel DC; Shroyer TW; Kirklin JK; Bourge RC; Barr ML; Pitts DG; Starling RC
    J Heart Lung Transplant; 1994; 13(4):583-95; discussion 595-6. PubMed ID: 7947874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP; Patton PR; Meier-Kriesche HU; Li Q; Shenkman B; Fujita S; Reed A; Hemming AW; Kim RD; Howard RJ
    Clin Transpl; 2005; ():101-9. PubMed ID: 17424728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis.
    Garcia CE; Garcia RF; Gunson B; Christensen E; Neuberger J; McMaster P; Mirza DF
    Exp Clin Transplant; 2004 Jun; 2(1):183-8. PubMed ID: 15859926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
    Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.